Clinical trial

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

NCT01222572

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2010-12-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2010-12-01Date precision: month

Registry last updated2015-06-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Lung Cancerunresolved

NSCLCunresolved

Interventions

Stereotactic boostRADIATION

Conventional RTRADIATION

EtoposideDRUG · verified · RxNorm: etoposide

CisplatinDRUG · verified · RxNorm: cisplatin

Sponsors & collaborators

Dana-Farber Cancer Institutelead sponsor

Brigham and Women's Hospitalcollaborator

Mapped research locations

BostonMassachusetts, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01222572 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.